Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AMERICAN HOSPITAL ASSOCIATION et al v. ERIC D. HARGAN et al
Case Number:
1:17-cv-02447
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
Companies
- American Hospital Association
- America's Essential Hospitals
- Association of American Medical Colleges
- Henry Ford Health System
Sectors & Industries:
-
January 01, 2018
Health Care Cases To Watch In 2018
Health care lawyers will kick off 2018 with a sprawling assortment of crucial cases to watch, including multibillion-dollar battles over Medicare reimbursement, Affordable Care Act spending and False Claims Act liability. Here are the key cases to watch in 2018.
-
December 21, 2017
Hospitals Urge Judge to Halt $1.6B Cut to Drug Payments
Hospital groups urged a D.C. federal judge Thursday to temporarily block a planned U.S. Department of Health and Human Services reimbursement tweak that will slash $1.6 billion from the 340B drug discount program, arguing the government overstepped its bounds and is open to a legal challenge.
-
November 13, 2017
Hospitals Sue HHS Over Big Cut To 340B Drug Payments
Hospital groups on Monday sued the U.S. Department of Health and Human Services in D.C. federal court for slashing $1.6 billion from the 340B drug discount program, calling the cut an unlawful overreach that would "thoroughly undermine" the program.